Showing results (321-330 of 760) with videos related to

Sort By:
Pageof 76
Blood|May 12, 2005
A SCID-hu in vivo model of human Waldenström macroglobulinemiaPierfrancesco Tassone, Paola Neri, Jeffery L Kutok, et al.
Molecular Cancer Therapeutics|October 14, 2003
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myelomaMasood A Shammas, Robert J Shmookler Reis, Masaharu Akiyama, et al.
British Journal of Haematology|October 20, 2017
Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myelomaDanka Cholujova, Zdenka Bujnakova, Erika Dutkova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2015
Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK StudyNoopur Raje, Robert Vescio, Charles W Montgomery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2023
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple MyelomaKeiji Kurata, Mehmet K Samur, Priscilla Liow, et al.
Expert Review of Hematology|January 26, 2012
Management of myeloma-associated renal dysfunction in the era of novel therapiesMahmoud R Gaballa, Jacob P Laubach, Robert L Schlossman, et al.
Oncogene|August 13, 2002
Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implicationsConstantine S Mitsiades, Nicholas Mitsiades, Vassiliki Poulaki, et al.
Blood|February 5, 2005
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorRoberto Bellucci, Edwin P Alyea, Sabina Chiaretti, et al.
British Journal of Haematology|September 4, 2009
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myelomaDan T Vogl, Edward A Stadtmauer, Paul G Richardson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myelomaS Vincent Rajkumar, Paul G Richardson, Martha Q Lacy, et al.
Pageof 76